177 related articles for article (PubMed ID: 36121153)
1. Preexisting Heterogeneity of Inducible Nitric Oxide Synthase Expression Drives Differential Growth of Mycobacterium tuberculosis in Macrophages.
Rutschmann O; Toniolo C; McKinney JD
mBio; 2022 Oct; 13(5):e0225122. PubMed ID: 36121153
[TBL] [Abstract][Full Text] [Related]
2. IRG1 and Inducible Nitric Oxide Synthase Act Redundantly with Other Interferon-Gamma-Induced Factors To Restrict Intracellular Replication of Legionella pneumophila.
Price JV; Russo D; Ji DX; Chavez RA; DiPeso L; Lee AY; Coers J; Vance RE
mBio; 2019 Nov; 10(6):. PubMed ID: 31719183
[TBL] [Abstract][Full Text] [Related]
3. STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection.
Queval CJ; Song OR; Deboosère N; Delorme V; Debrie AS; Iantomasi R; Veyron-Churlet R; Jouny S; Redhage K; Deloison G; Baulard A; Chamaillard M; Locht C; Brodin P
Sci Rep; 2016 Jul; 6():29297. PubMed ID: 27384401
[TBL] [Abstract][Full Text] [Related]
4. Nitric Oxide Modulates Macrophage Responses to
Braverman J; Stanley SA
J Immunol; 2017 Sep; 199(5):1805-1816. PubMed ID: 28754681
[TBL] [Abstract][Full Text] [Related]
5. The immunosuppressive effects of a novel recombinant LipQ (Rv2485c) protein of Mycobacterium tuberculosis on human macrophage cell lines.
Kumar A; Manisha ; Sangha GK; Shrivastava A; Kaur J
Microb Pathog; 2017 Jun; 107():361-367. PubMed ID: 28412202
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid promotes a decrease in mycobacterial survival by enhancing nitric oxide production in macrophages stimulated with IFN-γ.
Nieto-Patlán E; Serafín-López J; Wong-Baeza I; Pérez-Tapia SM; Cobos-Marín L; Estrada-Parra S; Estrada-García I; Chávez-Blanco AD; Chacón-Salinas R
Tuberculosis (Edinb); 2019 Jan; 114():123-126. PubMed ID: 30711151
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes.
Davis AS; Vergne I; Master SS; Kyei GB; Chua J; Deretic V
PLoS Pathog; 2007 Dec; 3(12):e186. PubMed ID: 18069890
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways.
Bekker LG; Freeman S; Murray PJ; Ryffel B; Kaplan G
J Immunol; 2001 Jun; 166(11):6728-34. PubMed ID: 11359829
[TBL] [Abstract][Full Text] [Related]
9. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung.
Cooper AM; Pearl JE; Brooks JV; Ehlers S; Orme IM
Infect Immun; 2000 Dec; 68(12):6879-82. PubMed ID: 11083808
[TBL] [Abstract][Full Text] [Related]
10. Macrophage control of phagocytosed mycobacteria is increased by factors secreted by alveolar epithelial cells through nitric oxide independent mechanisms.
Petursdottir DH; Chuquimia OD; Freidl R; Fernández C
PLoS One; 2014; 9(8):e103411. PubMed ID: 25089618
[TBL] [Abstract][Full Text] [Related]
11. Type I IFN Inhibits Alternative Macrophage Activation during Mycobacterium tuberculosis Infection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling.
Moreira-Teixeira L; Sousa J; McNab FW; Torrado E; Cardoso F; Machado H; Castro F; Cardoso V; Gaifem J; Wu X; Appelberg R; Castro AG; O'Garra A; Saraiva M
J Immunol; 2016 Dec; 197(12):4714-4726. PubMed ID: 27849167
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.
Lüder CG; Algner M; Lang C; Bleicher N; Gross U
Int J Parasitol; 2003 Jul; 33(8):833-44. PubMed ID: 12865083
[TBL] [Abstract][Full Text] [Related]
13. Identification of Mycobacterium tuberculosis counterimmune (cim) mutants in immunodeficient mice by differential screening.
Hisert KB; Kirksey MA; Gomez JE; Sousa AO; Cox JS; Jacobs WR; Nathan CF; McKinney JD
Infect Immun; 2004 Sep; 72(9):5315-21. PubMed ID: 15322028
[TBL] [Abstract][Full Text] [Related]
14. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways.
Chan ED; Morris KR; Belisle JT; Hill P; Remigio LK; Brennan PJ; Riches DW
Infect Immun; 2001 Apr; 69(4):2001-10. PubMed ID: 11254551
[TBL] [Abstract][Full Text] [Related]
15. Human renal epithelial cells express iNOS in response to cytokines but not bacteria.
Poljakovic M; Karpman D; Svanborg C; Persson K
Kidney Int; 2002 Feb; 61(2):444-55. PubMed ID: 11849384
[TBL] [Abstract][Full Text] [Related]
16. Novel role of the nitrite transporter NirC in Salmonella pathogenesis: SPI2-dependent suppression of inducible nitric oxide synthase in activated macrophages.
Das P; Lahiri A; Lahiri A; Chakravortty D
Microbiology (Reading); 2009 Aug; 155(Pt 8):2476-2489. PubMed ID: 19520723
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line.
Rockett KA; Brookes R; Udalova I; Vidal V; Hill AV; Kwiatkowski D
Infect Immun; 1998 Nov; 66(11):5314-21. PubMed ID: 9784538
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
19. Interferon-γ, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages.
Robinson CM; Jung JY; Nau GJ
Cytokine; 2012 Oct; 60(1):233-41. PubMed ID: 22749533
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase.
Ehrt S; Schnappinger D; Bekiranov S; Drenkow J; Shi S; Gingeras TR; Gaasterland T; Schoolnik G; Nathan C
J Exp Med; 2001 Oct; 194(8):1123-40. PubMed ID: 11602641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
